Mitotic quiescence in hepatic cancer stem cells: An incognito mode

Oncology Reviews
Kandasamy Ashokachakkaravarthy, Biju Pottakkat

Abstract

Hepatocellular carcinoma represents one of the most aggressive cancers with high recurrence rates. The high recurrence is a major problem in the management of this disease. Cancer stem cells (CSCs) are often regarded as the basis of cancer recurrence. The anti-proliferative therapy kills the proliferating cells but induces mitotic quiescence in CSCs which remain as residual dormant CSCs. Later on, withdrawal of treatment reactivates the residual CSCs from dormancy to produce new cancer cells. The proliferation of these newly formed cancer cells initiates new tumor formation in the liver leading to tumor recurrence. HCC cells evade the immune surveillance via modulating the key immune cells by alpha feto-protein (AFP) secreted from CSCs or hepatic progenitor cells. This AFP mediated immune evasion assists in establishing new tumors by cancer cells in the liver. In this review, we will summarise the CSC mechanisms of recurrence, mitotic quiescence, dormancy and reactivation of CSCs, metastasis and immune evasion of hepatocellular carcinoma.

References

Jan 1, 1977·Annual Review of Medicine·T B Tomasi
Jul 29, 1977·Science·A W Hamburger, S E Salmon
Dec 1, 1986·British Journal of Obstetrics and Gynaecology·N S Nicholas, G S Panayi
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A Zetterberg, O Larsson
Jan 1, 1981·Advances in Cancer Research·E F WheelockJ Levich
Mar 20, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S Cooper
Apr 15, 1999·Seminars in Cancer Biology·G I Abelev, T L Eraiser
Aug 6, 1999·The American Journal of Pathology·X ZhuM A Smith
Nov 2, 2001·Nature·T ReyaI L Weissman
Sep 11, 1954·British Medical Journal·G HADFIELD
Mar 25, 2004·World Journal of Gastroenterology : WJG·Qi-Gen LiFeng-Qi Jia
Jun 3, 2005·Cancer Research·Catherine M Shachaf, Dean W Felsher
Jun 9, 2005·Critical Reviews in Clinical Laboratory Sciences·V ZieglschmidO Böcher
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Haruyasu MurakamiMasayuki Miyake
Mar 3, 2006·PLoS Biology·Hilary A CollerJames M Roberts
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takahiro TokuharaMasayuki Miyake
Jul 25, 2006·Nature·Andrei V KrivtsovScott A Armstrong
Aug 18, 2006·Nature·Alison Abbott
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marija BalicRichard J Cote
Jun 16, 2007·Gastroenterology·Stephanie MaXin-Yuan Guan
Jun 23, 2007·Stem Cells·C Bart RountreeGay M Crooks
Jul 25, 2007·Annual Review of Cell and Developmental Biology·Neethan A LoboMichael F Clarke
Jul 10, 2008·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Stewart Sell
May 28, 2009·Cell Cycle·Zoya N DemidenkoMikhail V Blagosklonny
Jan 6, 2011·Cancer Science·Malin WickströmJoachim Gullbo
Mar 1, 2006·Seminars in Interventional Radiology·Ashwin AnanthakrishnanKia Saeian
Mar 24, 2012·Cancer Cell·Jeffrey A MageeSean J Morrison
May 2, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ines Martin-PaduraAlfonso Calvo
Jun 13, 2012·International Journal of Hepatology·Franck Chiappini
Jul 11, 2012·Journal of Cellular Physiology·Brian I CarrAngela Tafaro
Jan 1, 2010·Oncology Letters·Hidehiro TajimaYoh Zen
Oct 31, 2012·Digestive Diseases·Nathalie SchmidtRobert Thimme

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
surgical resection

Related Concepts

Related Papers

Cellular and Molecular Life Sciences : CMLS
Hong QiuGaoliang Ouyang
Critical Reviews in Oncogenesis
Merve ErkisaEngin Ulukaya
Pharmacology & Therapeutics
Yusuke ShiozawaRussell S Taichman
© 2021 Meta ULC. All rights reserved